RU2014134634A - DOSAGE FORM BASED BY BUTILAMINOHYDROXYPROPXYPHENOXYMETHyl METHYLOXADIAZOL - Google Patents
DOSAGE FORM BASED BY BUTILAMINOHYDROXYPROPXYPHENOXYMETHyl METHYLOXADIAZOL Download PDFInfo
- Publication number
- RU2014134634A RU2014134634A RU2014134634A RU2014134634A RU2014134634A RU 2014134634 A RU2014134634 A RU 2014134634A RU 2014134634 A RU2014134634 A RU 2014134634A RU 2014134634 A RU2014134634 A RU 2014134634A RU 2014134634 A RU2014134634 A RU 2014134634A
- Authority
- RU
- Russia
- Prior art keywords
- dosage form
- butilaminohydroxypropxyphenoxymethyl
- methyloxadiazol
- form based
- hydroxypropoxyphenoxymethyl
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title claims abstract 3
- DGHJKOUXAHNRAP-UHFFFAOYSA-N 4-methyloxadiazole Chemical compound CC1=CON=N1 DGHJKOUXAHNRAP-UHFFFAOYSA-N 0.000 title 1
- QBWJZZOQHMSJAT-UHFFFAOYSA-N OCCCOCC=1N=NOC1COC1=CC=CC=C1.C(CCC)N Chemical compound OCCCOCC=1N=NOC1COC1=CC=CC=C1.C(CCC)N QBWJZZOQHMSJAT-UHFFFAOYSA-N 0.000 claims abstract 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract 4
- GRSWJYSXCCFPNA-UHFFFAOYSA-N 3-ethyl-4-methyl-1h-pyridin-2-one Chemical compound CCC1=C(C)C=CNC1=O GRSWJYSXCCFPNA-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000007864 aqueous solution Substances 0.000 claims abstract 2
- 229960003080 taurine Drugs 0.000 claims abstract 2
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Лекарственная форма на основе бутиламиногидроксипропоксифеноксиметил метилоксадиазола в виде водного раствора, содержащая бутиламиногидроксипропоксифеноксиметил метилоксадиазол в количестве от 0,5% до 2%, таурин от 0,5% до 4% и метилэтилпиридинол от 0,5% до 2% в пересчете на общую массу.A dosage form based on butylamine hydroxypropoxyphenoxymethyl methyloxadiazole in the form of an aqueous solution containing butylamine hydroxypropoxyphenoxymethyl methyloxadiazole in an amount of from 0.5% to 2%, taurine from 0.5% to 4% and methylethylpyridinol from 0.5% to 2% based on the total weight.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014134634/15A RU2585400C2 (en) | 2014-08-26 | 2014-08-26 | Dosage form based on butylaminohydroxypropoxyphenoxymethyl methyloxadiazole |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2014134634/15A RU2585400C2 (en) | 2014-08-26 | 2014-08-26 | Dosage form based on butylaminohydroxypropoxyphenoxymethyl methyloxadiazole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2014134634A true RU2014134634A (en) | 2016-03-20 |
| RU2585400C2 RU2585400C2 (en) | 2016-05-27 |
Family
ID=55530690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2014134634/15A RU2585400C2 (en) | 2014-08-26 | 2014-08-26 | Dosage form based on butylaminohydroxypropoxyphenoxymethyl methyloxadiazole |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2585400C2 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2662364C2 (en) * | 2016-12-02 | 2018-07-25 | Общество с ограниченной ответственностью "ПРОФИТ ФАРМ" | Method for cataract treatment and eye drops for implementation thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2191013C2 (en) * | 2000-10-04 | 2002-10-20 | Федеральное унитарное предприятие "Московский эндокринный завод" | Antiglaucomatous preparation |
| RU2261714C1 (en) * | 2004-04-27 | 2005-10-10 | Государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" им. акад. С.Н. Федорова Министерства здравоохранения Российской Федерации" | Method for treatment of partial optic nerve atrophy in children |
-
2014
- 2014-08-26 RU RU2014134634/15A patent/RU2585400C2/en active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2585400C2 (en) | 2016-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018500894A1 (en) | Aqueous pharmaceutical formulation comprising anti-pd-l1 antibody avelumab | |
| CY1122796T1 (en) | IMPROVED PHARMACEUTICAL FORMS OF ADENOS | |
| CL2016002455A1 (en) | Multispecific antibodies. | |
| CY1118168T1 (en) | DOUBLE SPECIAL ANTIBODIES AGAINST CD3EXYLON AND BCMA | |
| EA201890441A1 (en) | MONOCLONAL ANTIBODIES AGAINST BCMA | |
| EA201791467A1 (en) | AQUEOUS OPHTHALMIC SOLUTION | |
| TR201905829T4 (en) | A refrigerator. | |
| EA201691259A1 (en) | REGULATORS Nrf2 | |
| PH12017502255B1 (en) | Nrf2 regulators | |
| EA201790266A1 (en) | INDOLS FOR USE IN INFECTIONS CAUSED BY THE FLU VIRUS | |
| EA201790410A1 (en) | CONTAINING ZINEOL COMPOSITION FOR BODY APPLICATION | |
| UA115373C2 (en) | AMG 416 (VELCALSETID) STABLE LIQUID COMPOSITION | |
| EA201691982A1 (en) | 5,6-Disposable Pyridine-2-Carboxamides as Agonists of Cannabinoid Receptors | |
| EA201791992A1 (en) | GRELIN-O-ACYLTRANSFERASE INHIBITORS | |
| EA201691983A1 (en) | Pyridine-2-amides suitable as agonists of CB2 | |
| EA201792000A1 (en) | GRELIN-O-ACYLTRANSFERASE INHIBITORS | |
| CR20170090A (en) | TERAHYDROQUINOLINE DERIVATIVES AS BROMODOMINUM INHIBITORS | |
| EA201692028A1 (en) | APPLICATION OF SUBSTITUTED OXOTETRAHYDROCHINOLINYL SULPHONAMIDES OR THEIR SALTS TO IMPROVE THE STRESS RESISTANCE OF PLANTS | |
| ECSP16096831A (en) | DERIVATIVES OF NAPHTHYRIDINADIONA | |
| BR112016027455A2 (en) | ppar modulators | |
| EA201692569A1 (en) | POLYMIXINS WITH LOW DEGREE OF SUBSTITUTION AND COMPOSITIONS CONTAINING THEM | |
| EA201790809A1 (en) | COMPOSITION FOR HAIR CLIMBING | |
| TR201819920T4 (en) | Ophthalmic compositions for use in the treatment of dry eye syndrome. | |
| RU2014134634A (en) | DOSAGE FORM BASED BY BUTILAMINOHYDROXYPROPXYPHENOXYMETHyl METHYLOXADIAZOL | |
| FR3017029B1 (en) | ACTIVE NUTRITIONAL PRINCIPLE OBTAINED FROM ANGUSTIFOLIUM VACCINE, COMPOSITION CONTAINING THE SAME AND USE THEREOF |